- 関
- incadronate、incadronic acid
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- [Long-term and high-dose bisphosphonate administration causes no bone over-mineralization].
- Liu C1, Cao YP, Yang X, Mashiba T, Mori S.
- Zhonghua yi xue za zhi.Zhonghua Yi Xue Za Zhi.2009 Nov 17;89(42):2968-71.
- OBJECTIVE: To evaluate the effects of long-term bisphosphonate administration (incadronate) upon the mean degree of secondary bone mineralization.METHODS: Thirty adult beagles were divided randomly into three groups of CNT, YML and YMH based upon their body weights (5 males and 5 females in each gro
- PMID 20137705
- Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs.
- Saito M1, Mori S, Mashiba T, Komatsubara S, Marumo K.
- Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.Osteoporos Int.2008 Sep;19(9):1343-54. doi: 10.1007/s00198-008-0585-3. Epub 2008 Mar 29.
- Collagen cross-linking is a determinant of bone quality. A three-year treatment of bisphosphonate-incadronate disodium-in beagles increased degree of mineralization, collagen maturity, and pentosidine, a compound with advanced glycation end products. The treatment had no effect on the total amount o
- PMID 18373056
- Bisphosphonate and low-dose dexamethasone treatment for patients with hormone-refractory prostate cancer.
- Ueda T1, Suzuki H, Akakura K, Ishihara M, Kamiya N, Komiya A, Shimbo M, Suyama T, Sakamoto S, Ichikawa T.
- Hinyokika kiyo. Acta urologica Japonica.Hinyokika Kiyo.2006 Jul;52(7):515-21.
- We evaluated the effects of bisphosphonate (BP) treatment in five patients with hormone-refractory prostate cancer (HRPC), experiencing bone pain from metastases to the bone, and assessed changes in serum prostate specific antigen (PSA) levels, bone pain, and quality of life (QOL). Treatment with in
- PMID 16910582
Japanese Journal
- 再燃前立腺癌患者に対するビスホスホネート・低容量デキサメサゾン治療
- 植田 健,鈴木 啓悦,赤倉 功一郎
- 泌尿器科紀要 52(7), 515-521, 2006-07
- … Treatment with incadronate disodium (10 mg) in saline was administered at 2-week intervals for a total of 6 times. …
- NAID 120001159920
- Incadronate disodium は, ラットアジュバント関節炎による傍関節炎骨萎縮と関節破壊を遅延、抑制する
- 秋山 知之,森 諭史,真柴 賛,土橋 浩章,小松原 悟史,宮本 賢作,曹 永平,乗松 尋道
- 日本骨形態計測学会雑誌 = Journal of Japanese Society of Bone Morphometry 12(2), 63, 2002-05-15
- NAID 10012306018
Related Links
- INCADRONATE DISODIUM [会社名] 製:山之内製薬 発:山之内製薬 [組成] 1管5mL中 インカドロン酸二ナトリウム10mg [剤形] 注射:液剤 [識別(カナ)] ムシヨクチヨウメイ [貯法] 室温 [使用期限] 有 [効能・効果] 悪性腫瘍による高 ...
- Incadronate concentrates into the bone as a target organ after intravenous administration of incadronate disodium. Mature osteoclasts has take up incadronate from the bone surface and convert it from an active to an inactive form. As ...
★リンクテーブル★
[★]
- 英
- incadronate、incadronic acid、incadronate disodium
- 関
- インカドロネート、インカドロン酸二ナトリウム
[★]
- 英
- incadronate disodium
- 関
- インカドロン酸
[★]
- 関
- incadronate、incadronate disodium
[★]
インカドロン酸、インカドロネート
- 関
- incadronate disodium、incadronic acid